United States - English - NLM (National Library of Medicine)

hospira, inc. - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate 50 mg in 2 ml - fludarabine phosphate for injection, usp is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate, usp in previously untreated or non-refractory patients with cll have not been established. fludarabine phosphate, usp is contraindicated in those patients who are hypersensitive to this drug or its components.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate 50 mg in 2 ml - fludarabine phosphate for injection, usp is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate for injection, usp in previously untreated or non-refractory patients with cll have not been established. fludarabine phosphate for injection, usp is contraindicated in those patients who are hypersensitive to this drug or its components.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. (dba leucadia pharmaceuticals) - fludarabine phosphate (unii: 1x9vk9o1sc) (fludarabine - unii:p2k93u8740) - fludarabine phosphate 25 mg in 1 ml - fludarabine phosphate for injection, usp is indicated for the treatment of adult patients with b-cell chronic lymphocytic leukemia (cll) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. the safety and effectiveness of fludarabine phosphate for injection, usp in previously untreated or non-refractory patients with cll have not been established. fludarabine phosphate for injection is contraindicated in those patients who are hypersensitive to this drug or its components.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - fludarabine phosphate - concentrate for solution for injection/infusion - 25 milligram(s)/millilitre - purine analogues; fludarabine

Canada - English - Health Canada

hospira healthcare ulc - fludarabine phosphate - powder for solution - 50mg - fludarabine phosphate 50mg - antineoplastic agents

Canada - English - Health Canada

omega laboratories limited - fludarabine phosphate - liquid - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Canada - English - Health Canada

mylan pharmaceuticals ulc - fludarabine phosphate - solution - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Canada - English - Health Canada

teva canada limited - fludarabine phosphate - solution - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Canada - English - Health Canada

fresenius kabi canada ltd - fludarabine phosphate - solution - 25mg - fludarabine phosphate 25mg - antineoplastic agents

Canada - English - Health Canada

fresenius kabi canada ltd - fludarabine phosphate - powder for solution - 50mg - fludarabine phosphate 50mg - antineoplastic agents